Advanced search
Publication Cover
Expert Review of Neurotherapeutics Volume 6, 2006 - Issue 9
Submit an article Journal homepage
112
Views
18
CrossRef citations to date
0
Altmetric
Drug Profile

Rotigotine for the treatment of Parkinson’s disease

John C Morgan Movement Disorders Program, Department of Neurology, Medical College of Georgia,1429 Harper Street, HF-1121 Augusta, GA 30912, USA Department of Veterans Affairs Medical Center, Neurology Service, One Freedom Way, Augusta, GA 30904, USA. [email protected]
&
Kapil D Sethi Movement Disorders Program, Department of Neurology, Medical College of Georgia,1429 Harper Street, HF-1121 Augusta, GA 30912, USA . [email protected]
Pages 1275-1282 | Published online: 10 Jan 2014

Citations (18)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Jon Stoessl. (2008) Potential therapeutic targets for Parkinson's disease. Expert Opinion on Therapeutic Targets 12:4, pages 425-436.
Read now
Ubaldo Bonuccelli & Roberto Ceravolo. (2008) The safety of dopamine agonists in the treatment of Parkinson's disease. Expert Opinion on Drug Safety 7:2, pages 111-127.
Read now
Christopher Kenney & Joseph Jankovic. (2007) Rotigotine transdermal patch in the treatment of Parkinson’s disease and restless legs syndrome. Expert Opinion on Pharmacotherapy 8:9, pages 1329-1335.
Read now

Articles from other publishers (15)

Wolfgang H. Jost. 2022. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy 3293 3308 .
Donald J. AbrahamOla A.M. Ghoneim & Raymond G. Booth. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery 1 46 .
Sara Silva, António Almeida & Nuno Vale. (2021) Importance of Nanoparticles for the Delivery of Antiparkinsonian Drugs. Pharmaceutics 13:4, pages 508.
Crossref
Wolfgang H. Jost. 2020. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy 1 17 .
L.P. Kotra & J. Park. 2017. Comprehensive Medicinal Chemistry III. Comprehensive Medicinal Chemistry III 439 473 .
. 2016. Meyler's Side Effects of Drugs. Meyler's Side Effects of Drugs 257 259 .
Toshio Nakaki. 2014. A worldwide yearly survey of new data in adverse drug reactions and interactions. A worldwide yearly survey of new data in adverse drug reactions and interactions 255 272 .
Rupam Borgohain, Rukmini Mridula Kandadai, Afshan Jabeen & Meena A. Kannikannan. (2011) Nonmotor outcomes in Parkinson’s disease: is deep brain stimulation better than dopamine replacement therapy?. Therapeutic Advances in Neurological Disorders 5:1, pages 23-41.
Crossref
Donald J. AbrahamRaymond G. Booth, John L. Neumeyer & Ross J. Baldessarini. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery 529 568 .
Peter Jenner, Michael Könen-Bergmann, Cornelia Schepers & Sebastian Haertter. (2009) Pharmacokinetics of a Once-Daily extended-release formulation of pramipexole in healthy male volunteers: Three studies. Clinical Therapeutics 31:11, pages 2698-2711.
Crossref
K.A. Stockwell, D. Scheller, S. Rose, M.J. Jackson, K. Tayarani-Binazir, M.M. Iravani, L.A. Smith, C.W. Olanow & P. Jenner. (2009) Continuous administration of rotigotine to MPTP-treated common marmosets enhances anti-parkinsonian activity and reduces dyskinesia induction. Experimental Neurology 219:2, pages 533-542.
Crossref
Yahya Choonara, Viness Pillay, Lisa Du Toit, Girish Modi, Dinesh Naidoo, Valence Ndesendo & Sibongile Sibambo. (2009) Trends in the Molecular Pathogenesis and Clinical Therapeutics of Common Neurodegenerative Disorders. International Journal of Molecular Sciences 10:6, pages 2510-2557.
Crossref
Ludy Shih & Daniel Tarsy. 2009. Pharmacology and Therapeutics. Pharmacology and Therapeutics 651 662 .
Wolfgang H. Oertel, Heike Benes, Diego Garcia-Borreguero, Peter Geisler, Birgit Högl, Bernd Saletu, Claudia Trenkwalder, Kenneth W. Sommerville, Erwin Schollmayer, Ralf Kohnen & Karin Stiasny-Kolster. (2008) Efficacy of rotigotine transdermal system in severe restless legs syndrome: A randomized, double-blind, placebo-controlled, six-week dose-finding trial in Europe. Sleep Medicine 9:3, pages 228-239.
Crossref
Shridhar Hegde & Michelle Schmidt. 2007. Annual Reports in Medicinal Chemistry Volume 42. Annual Reports in Medicinal Chemistry Volume 42 505 554 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.